Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2015 05/21/2015 05/22/2015 05/26/2015 05/27/2015 Date
164.44(c) 168.57(c) 171.94(c) 165.94(c) 168.12 Last
1 765 109 2 653 367 2 570 610 2 002 338 1 605 813 Volume
+1.53% +2.51% +2.00% -3.49% +1.31% Change
More quotes
Financials ($)
Sales 2015 2 634 M
EBIT 2015 1 168 M
Net income 2015 528 M
Finance 2015 194 M
Yield 2015 -
Sales 2016 3 351 M
EBIT 2016 1 564 M
Net income 2016 825 M
Finance 2016 1 010 M
Yield 2016 -
PER 2015 65,70
PER 2016 41,00
EV / Sales 2015 12,5x
EV / Sales 2016 9,58x
Capitalization 33 118 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
05/27 | 10:00amPresentation
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
05/24 ALEXION PHARMACEUTICALS : Behind this door to a hospital pharmacy is a drug that..
05/18DJEndo to Buy Generics Maker Par Pharma for $8 Billion -- 4th Update
05/18DJEndo to Buy Generics Maker Par Pharma for $8 Billion -- 2nd Update
05/18DJEndo to Buy Generics Maker Par Pharma for About $8 Billion -- Update
05/15 ALEXION PHARMACEUTICALS : Technical Notes Covering Biotech Stocks -- Aeterna Zen..
05/12 ALEXION PHARMACEUTICALS : Submission of Matters to a Vote of Security Holders (f..
05/11 ALEXION PHARMACEUTICALS : to Present at Investor Conferences
05/07 NEXT LEVEL STOCKS : Follow the Gileader
More news
Sector news : Biopharmaceuticals
05:46pDJTeva Reports Small Stake in Mylan
05:33p ACTAVIS : Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of I..
05:04p GILEAD SCIENCES : to Present at the Bernstein 31st Annual Strategic Decisions Co..
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/24 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
05/20 Why I Bought The Dips In Both Gilead And Achillion Today
05/19 Consolidation Is Good - Cramer's Mad Money (5/18/15)
05/11 Yellen Sounds A Warning, Nasdaq Falls But Biotech Hangs On
05/11 Merger Arbitrage Mondays - May 11, 2015


Comments 
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions